A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...

Pneumagen has announced the publication of phase 2 data showing its antiviral therapy, Neumifil, significantly reduced ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and ...

Cidara Therapeutics has reported encouraging top-line outcomes from the Phase IIb NAVIGATE trial of the investigational ...

Influenza is considered one of the main public health problems in developed countries, being responsible for epidemics that affect 10% of the population each year. Influenza viruses can also cause ...

The likelihood of antiviral prescribing and dispensing among patients with influenza varied by care setting, patient age, and underlying medical conditions.

Influenza A (H1N1)pdm09 virus resistance to baloxavir, oseltamivir and sialic acid mimetics in single and dual therapies: Insights from human airway epithelia and murine models. Antiviral Res. 2025 ...